Skip to main content
HairCited

Mikroiğneleme için Androgenetik Alopesi

A

52 çalışmaya (5 meta-analyses, 11 RCTs), toplam 8,451 katılımcıyla dayanmaktadır. 44/52 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Microneedling has strong, well-established evidence for androgenetic alopecia, particularly when combined with topical minoxidil, and is one of the best-supported adjunct therapies for pattern hair loss.

  • 44 out of 52 studies show positive effects, supported by 5 meta-analyses and 11 RCTs
  • Most effective when combined with topical minoxidil, significantly boosting its effectiveness
  • Stimulates growth factors and wound-healing pathways that support hair follicle regeneration
  • Both professional and at-home microneedling approaches have demonstrated benefits

Key Study Findings

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo Etki: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) vs: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment Etki: None None

Popülasyon: Adult males with androgenetic alopecia

Review
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Etki: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Etki: None None

Key Statistics

62

Çalışmalar

8574

Katılımcılar

Positive

A

Derece

Referenced Papers

Aesthetic plastic surgery 2025 14 atıf
Dermatology (Basel, Switzerland) 2024 14 atıf
Journal of cosmetic … 2024 11 atıf
Journal of clinical … 2024 10 atıf
Clinical, cosmetic and … 2023 58 atıf
Faculty reviews 2022 44 atıf
Journal of cosmetic … 2022 35 atıf
Dermatologic surgery : … 2022 15 atıf
Dermatologic surgery : … 2021 58 atıf
Dermatologic therapy 2020 48 atıf
Journal of plastic, … 2018 137 atıf
Journal of the … 2018 114 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

hairloss:
1.5 mm depth, weekly sessions

Üst sınır: Not applicable

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
None -- Mixed --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Mixed --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Positive 631
None -- Mixed --

En iyi alım zamanı: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Bildirilen Yan Etkiler

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Bilinen Etkileşimler

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Tolere edilebilir üst alım: Not applicable

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Mikroiğneleme help with Androgenetik Alopesi?
Based on 62 studies with 8,574 participants, there is strong evidence from multiple clinical trials that Mikroiğneleme may support Androgenetik Alopesi management. Our evidence grade is A (Strong Evidence).
How much Mikroiğneleme should I take for Androgenetik Alopesi?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Mikroiğneleme?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Mikroiğneleme and Androgenetik Alopesi?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 62 peer-reviewed studies with 8,574 total participants. The overall direction of effect is positive.

Related Evidence

Mikroiğneleme diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.